STK11 and Buschke-Ollendorff syndrome: In line with the literature, the results of the study suggest that the downregulation of LKB1 may lead to tissue fibrosis, facilitating the development of BOS and that this protein could, therefore, be a reliable biomarker of risk of BOS.